Abstract
This editorial overview is aimed at reviewing all the work published by the Journal Endocrine Metabolic Immune Disorders-Drug Targets over the period 2012-2014. The main body of publications has been divided either into a section based on special issues and meeting proceedings or various specific sections according to different types of pathologies related to the field of endocrine metabolic immune disorder-drug targeting.
Keywords: Drugs, endocrinology, immunity, metabolism, nutrition.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Volume: 15 Issue: 1
Author(s): Thea Magrone and Emilio Jirillo
Affiliation:
Keywords: Drugs, endocrinology, immunity, metabolism, nutrition.
Abstract: This editorial overview is aimed at reviewing all the work published by the Journal Endocrine Metabolic Immune Disorders-Drug Targets over the period 2012-2014. The main body of publications has been divided either into a section based on special issues and meeting proceedings or various specific sections according to different types of pathologies related to the field of endocrine metabolic immune disorder-drug targeting.
Export Options
About this article
Cite this article as:
Magrone Thea and Jirillo Emilio, Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview, Endocrine, Metabolic & Immune Disorders - Drug Targets 2015; 15 (1) . https://dx.doi.org/10.2174/187153031501150302220219
DOI https://dx.doi.org/10.2174/187153031501150302220219 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bisphenol A as a Factor in the Mosaic of Autoimmunity
Endocrine, Metabolic & Immune Disorders - Drug Targets Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Current Stem Cell Research & Therapy Telomeres, Senescence and Longevity: The Role of Oxidative Stress and Antioxidants
Current Pharmacogenomics The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis
Anti-Cancer Agents in Medicinal Chemistry Valve in Valve Trans-Catheter Aortic Valve Replacement Followed by LVAD Deactivation in the Setting of Recovered Systolic Function
Current Cardiology Reviews Preface
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease
Current Medicinal Chemistry The Use of Exercise Echocardiography in the Evaluation of Mitral Regurgitation
Current Cardiology Reviews Antithrombotic Treatment in Cardiomyopathies
Current Pharmaceutical Design The Fluctuations of Melatonin and Copeptin Levels in Blood Serum During Surgical Stress Regarding the Pediatric Population
Current Pediatric Reviews Endothelial Microparticles: Mediators or Markers of Endothelial Cell Dysfunction?
Current Hypertension Reviews Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors
Current Cancer Drug Targets Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design Pathogenetic Pathways of Cardiorenal Syndrome and their Possible Therapeutic Implications
Current Pharmaceutical Design Phosphorylated and O-GlcNAc Modified IRS-1 (Ser1101) and -2 (Ser1149) Contribute to Human Diabetes Type II
Protein & Peptide Letters A Review of Patents Relating to Therapeutic Angiogenesis Using Endothelial Progenitors and Other Vasculogenesis-Related Cell Types
Recent Patents on Regenerative Medicine Experimental Antiarrhythmic Targets: CaMKII Inhibition – Ready for Clinical Evaluation?
Current Medicinal Chemistry Immunophilins and Coupled Gating of Ryanodine Receptors
Current Topics in Medicinal Chemistry Synthetic Cannabinoids as Drugs of Abuse
Current Drug Abuse Reviews The Anti-fibrotic Hormone Relaxin is not Reno-protective, Despite Being Active, in an Experimental Model of Type 1 Diabetes
Protein & Peptide Letters